In the last trading session, 1.14 million shares of the Oncology Institute Inc (NASDAQ:TOI) were traded, and its beta was 0.04. Most recently the company’s share price was $2.5, and it changed around -$0.06 or -2.34% from the last close, which brings the market valuation of the company to $229.79M. TOI currently trades at a discount to its 52-week high of $3.50, offering almost -40.0% off that amount. The share price’s 52-week low was $0.13, which indicates that the current value has risen by an impressive 94.8% since then. We note from Oncology Institute Inc’s average daily trading volume that its 10-day average is 2.2 million shares, with the 3-month average coming to 1.80 million.
Oncology Institute Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended TOI as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Oncology Institute Inc (NASDAQ:TOI) trade information
Instantly TOI has showed a red trend with a performance of -2.34% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.64 on recent trading dayincreased the stock’s daily price by 5.3%. The company’s shares are currently up 412.40% year-to-date, but still up 21.95% over the last five days. On the other hand, Oncology Institute Inc (NASDAQ:TOI) is -10.39% down in the 30-day period. We can see from the shorts that 2.41 million shares have been sold at a short interest cover period of 1.11 day(s).
The consensus price target as assigned by Wall Street analysts is $8, which translates to bulls needing to increase their stock price by 68.75% from its current value. Analyst projections state that TOI is forecast to be at a low of $6 and a high of $10.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -488.57%.
TOI Dividends
Oncology Institute Inc’s next quarterly earnings report is expected to be released on 2024-Aug-13.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.22% of Oncology Institute Inc shares, and 34.63% of them are in the hands of institutional investors. The stock currently has a share float of 38.15%. Oncology Institute Inc stock is held by 51.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 6.4005% of the shares, which is about 4.75 million shares worth $2.19 million.
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), with 4.5263% or 3.36 million shares worth $1.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 1.27 shares worth $3.18 million, making up 1.39% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 422.98 shares worth around $1.06 million, which represents about 0.46% of the total shares outstanding.
